The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene. 2001

H Arai, and K I Miyamoto, and M Yoshida, and H Yamamoto, and Y Taketani, and K Morita, and M Kubota, and S Yoshida, and M Ikeda, and F Watabe, and Y Kanemasa, and E Takeda
Department of Clinical Nutrition, School of Medicine, University of Tokushima, Japan.

The major physiological activity of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] is the regulation of calcium absorption in the small intestine, and the level of vitamin D receptor (VDR) is an important factor in this regulation. In a previous study, we indicated-that the caudal-related homeodomain Cdx-2 played an important role in the intestine-specific transcription of the human VDR gene. In this study, the polymorphism was identified in the core sequence 5'-ATAAAAACTTAT-3' in the Cdx-2 binding site in the VDR gene promoter. In 261 Japanese women with genotyped VDR polymorphisms, 48 were genotype Cdx-A (adenine at -3731 nucleotides [nt] relative to the transcription start site of human VDR gene 5-ATAAAAACTTAT), 82 were genotype Cdx-G (guanine at -3731 nt, 5'-GTAAAAACTTAT-3'), and 131 were genotype Cdx-A/G (heterozygote). In postmenopausal Japanese women, the bone mineral density (BMD) in the lumbar spine (L2-L4) with the Cdx-G homozygote was 12% lower than that with the Cdx-A homozygote (p < 0.05). In electrophoretic gel mobility shift assay (EMSA), the oligonucleotide with Cdx-G allele markedly decreased the binding to Cdx-2 compared with that in the Cdx-A allele. The transcriptional activity of the VDR promoter with Cdx-G allele was decreased to 70% of the Cdx-A allele. In addition, in the herpes simplex virus thymidine kinase promoter, the Cdx-2 binding element with the G allele showed significantly lower transcriptional activity than that of the A allele. Thus, the polymorphism in the Cdx-2 binding site of the VDR gene (Cdx-polymorphism) would affect the expression of VDR in the small intestine. In addition, this polymorphism may modulate BMD in postmenopausal Japanese women.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D005260 Female Females
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071616 CDX2 Transcription Factor An antennapedia-like homeodomain transcription factor that regulates the expression of multiple genes in the INTESTINAL MUCOSA. It plays a critical role in many processes from early differentiation to maintenance of the intestinal epithelial lining of both the small and large intestine. CDX2 Protein,Caudal Type Homeo Box 2 Protein,Caudal Type Homeo Box Transcription Factor 2,Caudal Type Homeobox Transcription Factor 2,Cdx-2 Protein,Cdx-2-3 Protein,Cdx-3 Protein,Homeobox Protein CDX-2,Homeobox Protein CDX2,Transcription Factor CDX2,CDX-2, Homeobox Protein,CDX2, Homeobox Protein,CDX2, Transcription Factor,Cdx 2 3 Protein,Cdx 2 Protein,Cdx 3 Protein,Homeobox Protein CDX 2

Related Publications

H Arai, and K I Miyamoto, and M Yoshida, and H Yamamoto, and Y Taketani, and K Morita, and M Kubota, and S Yoshida, and M Ikeda, and F Watabe, and Y Kanemasa, and E Takeda
February 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
H Arai, and K I Miyamoto, and M Yoshida, and H Yamamoto, and Y Taketani, and K Morita, and M Kubota, and S Yoshida, and M Ikeda, and F Watabe, and Y Kanemasa, and E Takeda
January 1996, Molecular and cellular biology,
H Arai, and K I Miyamoto, and M Yoshida, and H Yamamoto, and Y Taketani, and K Morita, and M Kubota, and S Yoshida, and M Ikeda, and F Watabe, and Y Kanemasa, and E Takeda
November 1996, The Journal of biological chemistry,
H Arai, and K I Miyamoto, and M Yoshida, and H Yamamoto, and Y Taketani, and K Morita, and M Kubota, and S Yoshida, and M Ikeda, and F Watabe, and Y Kanemasa, and E Takeda
May 2001, The Journal of biological chemistry,
H Arai, and K I Miyamoto, and M Yoshida, and H Yamamoto, and Y Taketani, and K Morita, and M Kubota, and S Yoshida, and M Ikeda, and F Watabe, and Y Kanemasa, and E Takeda
December 2011, Biochimica et biophysica acta,
H Arai, and K I Miyamoto, and M Yoshida, and H Yamamoto, and Y Taketani, and K Morita, and M Kubota, and S Yoshida, and M Ikeda, and F Watabe, and Y Kanemasa, and E Takeda
September 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
H Arai, and K I Miyamoto, and M Yoshida, and H Yamamoto, and Y Taketani, and K Morita, and M Kubota, and S Yoshida, and M Ikeda, and F Watabe, and Y Kanemasa, and E Takeda
January 2021, International journal of health sciences,
H Arai, and K I Miyamoto, and M Yoshida, and H Yamamoto, and Y Taketani, and K Morita, and M Kubota, and S Yoshida, and M Ikeda, and F Watabe, and Y Kanemasa, and E Takeda
August 2015, Medicine,
H Arai, and K I Miyamoto, and M Yoshida, and H Yamamoto, and Y Taketani, and K Morita, and M Kubota, and S Yoshida, and M Ikeda, and F Watabe, and Y Kanemasa, and E Takeda
January 2015, PloS one,
H Arai, and K I Miyamoto, and M Yoshida, and H Yamamoto, and Y Taketani, and K Morita, and M Kubota, and S Yoshida, and M Ikeda, and F Watabe, and Y Kanemasa, and E Takeda
August 2018, Immunogenetics,
Copied contents to your clipboard!